방사선량 관리 시장 : 시장 규모, 점유율, 동향 및 예측 - 컴포넌트별, 모달리티별, 용도별, 최종 사용자별, 지역별(2026-2034년)

The global radiation dose management market size was valued at USD 385.0 Million in 2025. The market is projected to reach USD 1,027.7 Million by 2034, exhibiting a CAGR of 11.18% from 2026-2034. North America currently dominates the market, holding a market share of over 38.5% in 2025 . The market is recording robust growth, fueled by expanding use of advanced imaging technologies, rising patient safety awareness, and strict regulatory standards. Healthcare providers are adopting AI-facilitated software to track radiation in real time, streamline imaging protocols, and enhance workflow efficiency. Increased demand from oncology, cardiology, and interventional procedures also drives market growth. Consistent innovation in dose tracking, reporting, and optimization tools guarantees safer diagnostics, driving adoption throughout healthcare facilities and playing an important role in the overall radiation dose management market share.

Increasingly, radiation dose management is spurred by the global focus on patient safety and enhanced adoption of advanced imaging technology throughout healthcare systems. As medical imaging technologies like CT scans, PET scans, and interventional radiology grow globally, there is an increased requirement for health care professionals to manage and regulate exposure to radiation. Global emphasis on the reduction of unnecessary radiation has been driven by long-term safety concerns as well as regulatory requirements that ensure safer diagnostic testing. Technological innovation in dose-tracking software, automated alert systems, and intelligent imaging protocols is facilitating hospitals and clinics to improve patient care without compromising diagnostic accuracy. As per the sources, in March 2025, DOSIsoft received FDA 510(k) clearance for PLANET(R) Onco Dose version 3.2, enabling expanded US clinical use for multiple radionuclides and targeted radiation therapy workflows. Furthermore, awareness campaigns and professional guidelines by global health agencies are promoting uniform dose management practices. This international focus guarantees that patient safety is an ongoing concern, with healthcare facilities increasingly incorporating radiation dose management solutions into imaging workflows in order to maximize clinical results, minimize exposure, and adhere to best practices in contemporary medical practice.

In the United States, dose management of radiation is highly driven by regulatory guidelines and the large number of imaging diagnostic procedures, with the market accounting for 77% share in 2024. Hospitals, outpatient imaging facilities, and specialty clinics are increasingly using advanced dose monitoring devices to sustain national standards and safeguard patient health. According to the sources, in May 2025, Philips launched the RADIQAL trial, a multicenter study enrolling 824 coronary artery disease patients across Europe and the US to evaluate its new ultra-low X-ray dose technology. Moreover, the increased application of high-resolution CT scans and interventional radiology procedures has led to an implementation of systematic dose monitoring, automated notification, and optimization algorithms by healthcare facilities, which has minimized unnecessary exposure to radiation. Federal and state legislation as well as professional recommendations from major medical societies underpin the need for uniform radiation protection practices. Additionally, increasing emphasis on value-based care and patient-centered practices motivates healthcare professionals to emphasize safety in conjunction with diagnostic efficacy. These elements combined propel the extensive use of radiation dose management solutions in America towards ensuring safer imaging processes with excellent diagnostic results.

RADIATION DOSE MANAGEMENT MARKET TRENDS:

Increasing Diagnostic Imaging Modalities

Accelerating application of diagnostic imaging modalities worldwide is a primary impetus for radiation dose management. As ultrasound, MRI, CT, PET, and X-ray imaging continue to grow throughout healthcare facilities, vast amounts of radiation dose information are produced, necessitating automatic collection and aggregation. Radiation dose management systems enable precise monitoring, analysis, and reporting of meaningful dose events, reducing the workload and enabling clinical decision-making. These systems allow healthcare professionals to track exposure levels continuously, minimize operational inefficiencies, and uphold patient safety requirements. Furthermore, the capacity for exporting dose data for reporting and compliance will enhance quality assurance and conform with emerging clinical protocols. Adoption of these systems guarantees improved control over exposure of patients during diagnostics, ensuring the safe and effective utilization of imaging technologies and aligning with global efforts to maximize radiation safety and uphold excellent medical standards.

Integration of Advanced Technologies

Artificial intelligence (AI) and the Internet of Things (IoT) are becoming highly embedded in radiation dose management, fueling market expansion. AI allows for the analysis of dose trends, forecasting of high-exposure incidents, and optimization of imaging protocols, while IoT sensors enable real-time monitoring of patient exposure. Such integration promotes patient safety by facilitating corrective measures in real time and minimizing human error, enabling more informed clinical decisions. IoT implementation in healthcare, projected at 87% by 2025, illustrates increasing dependence on networked, smart solutions. Such technological progress enables real-time monitoring, quicker detection of anomalies, and enhanced operational effectiveness. The radiation dose management market trends indicate that combining AI and IoT capabilities delivers precise, automated insights, improving safety standards and workflow effectiveness. The implementation of such innovative solutions place's healthcare centers at the forefront of optimizing imaging protocols while reducing redundant radiation exposure, further translating to overall patient care enhancements.

Increased Patient Safety and Regulatory Compliance Demand

Regulatory compliance and patient safety are intensely influencing the uptake of radiation dose management systems. These systems enable healthcare professionals to monitor radiation exposure history, identify inappropriate dose selection in a timely manner, and minimize the burden of manual data capture, especially for CT examinations. Government programs that support dose management and standardized protocols also boost adoption, mirroring world and regional agendas for safer imaging practice. Increasing healthcare spending, continued R&D efforts, and the widespread occurrence of chronic diseases, such as cancer, are some of the other drivers for demand. For the United States in 2025, over two million new cases of cancer have been projected, highlighting the urgent need for precise monitoring and tracking of the dose to ensure patient safety. Through the integration of compliance with safety and operating efficiency, radiation dose management systems are emerging as a necessary instrument in contemporary healthcare, facilitating risk mitigation and enhanced outcomes while maintaining the focus on patient care.

RADIATION DOSE MANAGEMENT INDUSTRY SEGMENTATION:

Analysis by Component:

• Software
  • Integrated Solution
  • Standalone Solution
• Services

Retaining 62% market share in 2025, software solutions are the cornerstones of radiation dose management market growth, facilitating accurate tracking, reporting, and optimization of radiation exposure in medical imaging procedures. These software applications are natively integrated with hospital information systems and imaging equipment to support real-time dose monitoring, automatic alerts, and advanced analytics. Through customizable dashboards and standardized reports, they enable healthcare providers to ensure regulatory compliance and enhance patient safety. Sophisticated algorithms and AI-based capabilities enable adaptive imaging protocols for optimal diagnostic results with minimum radiation usage. The increasing emphasis on patient-focused care and compliance with global guidelines further propels the use of software-based dose management solutions. Imaging centers and hospitals highly depend on these platforms for simplifying procedures, improving workflow efficiency, and facilitating clinical decision-making. With advancing technology, software continues to play an integral part in enabling radiation safety practices worldwide.

Analysis by Modality:

• Computed Tomography
• Fluoroscopy and Interventional Imaging
• Radiography and Mammography
• Nuclear Medicine

With 39.8% market share in 2025, computed tomography (CT) is one of the most important modalities pushing the demand for radiation dose management offerings, considering its extensive clinical application and comparatively higher radiation exposure than other imaging modalities. The sophisticated nature and accuracy needed for CT imaging mean proper radiological doses need to be monitored closely in order to protect patients. Dose management systems incorporated into CT scanners optimize scan parameters, reduce unnecessary exposure, and offer detailed logs for regulatory reporting. Use of iterative reconstruction technologies and automated exposure control improves imaging efficiency with less risk to the patient. Hospitals are progressively adopting these solutions as CT continues to be a first-line diagnostic modality for a range of conditions, such as cardiovascular, neurological, and oncologic assessments. With ongoing innovations in CT imaging technology, the use of dose management systems becomes inevitable to ensure high-quality imaging practices while keeping patient safety and compliance with best practices in contemporary healthcare top priorities.

Analysis by Application:

• Oncology
• Cardiology
• Orthopedic Applications
• Others

With 50.7% market share in 2025, oncology applications are a key area of concern for managing radiation doses, indicating high use of diagnostic imaging and radiotherapy treatments in cancer management. Reliable dose tracking is essential in oncology to reconcile treatment efficacy with patient safety, particularly in iterative imaging for tumor follow-up or treatment planning. Sophisticated dose management systems deliver detailed information regarding cumulative exposure for clinicians to refine imaging protocols and maximize therapeutic interventions. Such tools enable accurate documentation for regulatory reporting, aid quality assurance programs, and improve patient trust in care safety. As cancer rates boost worldwide and imaging becomes increasingly central to the treatment process, oncology maintains its pressure for solutions to manage radiation dose. Healthcare professionals rely more on such systems to ensure clinical validity, minimize unnecessary exposure, and that patients with repeated imaging are given the safest possible care for the duration of their treatment.

Analysis by End User:

• Hospitals
• Ambulatory Care Setting
• Others

With 57% market share in 2025, hospitals are the key end customers of radiation dose management solutions, which indicate the widespread application of diagnostic imaging and interventional procedures in clinical practice. Hospitals adopt dose management solutions to guarantee patient safety, compliance with regulations, and optimization of imaging workflows across various departments. Integration with electronic health records and radiology information systems provides centralized monitoring, automated alerts, and detailed reporting that sustain operational efficiency and clinical decision-making. The heightening focus on value-based care prompts hospitals to implement solutions that reduce unnecessary radiation with diagnostic accuracy intact. Furthermore, hospitals also invest in protocol standardization and staff training to leverage the fullest advantage of dose management systems. With expanding imaging volumes and patient safety as ever a top priority, hospitals increasingly become major drivers for the adoption and deployment of sophisticated radiation dose management solutions, showing dedication to quality care and regulatory compliance.

Regional Analysis:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America held 38.5% market share in 2025 and was the prominent region for radiation dose management adoption owing to well-developed healthcare infrastructure, large volumes of imaging procedures, and stringent regulatory requirements. The United States and Canada dominate the market with large-scale deployment of dose monitoring solutions in hospitals, outpatient imaging centers, and specialty clinics. Regional adoption is driven by an intense focus on patient safety, state and federal regulations, and professional standards requiring optimal radiation practices. Technological innovations such as AI-assisted dose tracking, automated alarms, and cloud-based reporting are extensively used in North American healthcare systems for increased compliance and operational efficiency. The growing attention on value-based care models also further drives the adoption of dose management solutions. With ongoing investment in advanced imaging and heightened awareness of radiation safety, North America is set to continue to lead the way in the use of extensive dose management technology to make imaging safer and more effective.

KEY REGIONAL TAKEAWAYS:

UNITED STATES RADIATION DOSE MANAGEMENT MARKET ANALYSIS

United States has witnessed a surge in radiation dose management adoption primarily due to the increasing prevalence of chronic diseases. For instance, 6 out of 10 Americans have one chronic disease and four out of 10 have two or more chronic diseases that account for ninety percent of the USD 4.5 Trillion annual health care costs in the nation. Rising incidences of conditions such as cardiovascular disorders, diabetes, and respiratory ailments have led to higher demand for medical imaging procedures like CT scans and X-rays. This frequent use of imaging technology has amplified concerns regarding patient radiation exposure, necessitating structured monitoring and control. Healthcare providers are prioritizing radiation dose management tools to ensure regulatory compliance and patient safety. Technological advancements in imaging software, integration with electronic health records, and emphasis on optimizing imaging protocols further support this trend.

ASIA PACIFIC RADIATION DOSE MANAGEMENT MARKET ANALYSIS

Asia-Pacific is experiencing a rapid rise in radiation dose management initiatives driven by the growing number of diagnostic facilities. For instance, in 2025, with over 300,000 diagnostic labs spread across the country, the diagnostic laboratories market in India. Expansion of hospitals, diagnostic imaging centers, and specialty clinics across urban and semi-urban regions has increased access to radiological services. This infrastructural growth fuels the need for systematic radiation monitoring to enhance patient safety and clinical outcomes. As advanced imaging procedures become more routine, there is a parallel demand for radiation dose optimization software and analytics platforms. Healthcare providers are adopting these solutions to meet evolving safety standards, ensure accurate imaging practices, and reduce unnecessary exposure.

EUROPE RADIATION DOSE MANAGEMENT MARKET ANALYSIS

Europe is observing a steady increase in radiation dose management adoption influenced by the growing geriatric population. According to WHO, the population aged 60 and older is rapidly growing in the WHO European Region. In 2021, there were 215 Million; by 2030, it is projected to be 247 Million, and by 2050, over 300 Million. With aging demographics comes a higher incidence of age-related illnesses requiring frequent diagnostic imaging. Older patients often undergo multiple scans, making radiation safety a priority across healthcare facilities. Radiation dose management systems help clinicians maintain optimal exposure levels and track cumulative doses for elderly individuals, ensuring long-term safety. The demand for personalized imaging protocols and automated dose reporting tools aligns with the continent's focus on preventive healthcare.

LATIN AMERICA RADIATION DOSE MANAGEMENT MARKET ANALYSIS

Latin America is strengthening its focus on radiation dose management as healthcare providers prioritize patient safety alongside diagnostic accuracy. Growing healthcare spending is driving hospitals and diagnostic centres to adopt advanced imaging technologies with integrated dose monitoring systems to minimize exposure risks. The expansion of private healthcare facilities is further encouraging investment in modern radiology equipment and software that enhance compliance with international safety standards. According to the Brazilian Federation of Hospitals (FBH) and the National Confederation of Health (CNSaude), of Brazil's 7,309 hospitals, 63% are private. Rising demand for oncology and cardiology imaging is fuelling awareness of optimized dose protocols, making radiation dose management a critical aspect of healthcare modernization.

MIDDLE EAST AND AFRICA RADIATION DOSE MANAGEMENT MARKET ANALYSIS

Middle East and Africa are experiencing higher adoption of radiation dose management solutions due to growing cancer cases. For instance, the Kingdom reported 27% of the GCC's total cancer cases, with an estimated 18,000 new diagnoses annually. Rising oncology diagnostics demand frequent imaging procedures, elevating concerns over radiation exposure. Healthcare systems are integrating dose monitoring tools to track patient exposure, optimize imaging protocols, and support radiation safety initiatives.

COMPETITIVE LANDSCAPE:

The competitive analysis of the radiation dose management market outlook is characterized by a varied array of international and local players that provide cutting-edge solutions to make patient care safer and more compliant with regulation. Firms are increasingly turning to software integration, real-time tracking, and artificial intelligence-based analytics to differentiate themselves and boost market share. Strategic collaborations with hospitals, imaging centers, and healthcare technology vendors are prevalent, facilitating widespread use of sophisticated dose management systems. Ongoing product refinement, such as automated alerts, customizable dashboards, and cloud-based reporting, enables providers to streamline workflows while preserving diagnostic confidence. Besides, regional growth and focused marketing are fueling competition as companies seek to take a greater portion of the increasing demand for radiation safety products. In this dynamic landscape, the radiation dose management market forecast indicates continued growth fueled by improving awareness of patient safety, innovations in technology, and expanding adoption of dose optimization strategies by healthcare providers globally.

The report provides a comprehensive analysis of the competitive landscape in the radiation dose management market with detailed profiles of all major companies, including:

• Bayer Pharmaceuticals (Bayer AG)
• General Electric Company
• INFINITT Healthcare Co. Ltd.
• Koninklijke Philips N.V.
• Medsquare
• Novarad Corporation
• PACSHealth LLC
• Qaelum, Sectra AB
• Siemens Healthcare Private Limited (Siemens AG)
• Volpara Health Limited

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Radiation Dose Management Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Component

• 6.1 Software
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Integrated Solution
    • 6.1.2.2 Standalone Solution
  • 6.1.3 Market Forecast
• 6.2 Services
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Modality

• 7.1 Computed Tomography
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Fluoroscopy and Interventional Imaging
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Radiography and Mammography
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Nuclear Medicine
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Application

• 8.1 Oncology
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Cardiology
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Orthopedic Applications
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Ambulatory Care Setting
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Bayer Pharmaceuticals (Bayer AG)
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 General Electric Company
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 INFINITT Healthcare Co. Ltd.
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 Koninklijke Philips N.V.
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Medsquare
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Novarad Corporation
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 PACSHealth LLC
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Qaelum
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 Sectra AB
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Siemens Healthcare Private Limited (Siemens AG)
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 Volpara Health Limited
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio